Mark S Forman is Chief Medical Officer of Ventyx Biosciences, Inc.. Currently has a direct ownership of 3,000 shares of VTYX, which is worth approximately $6,120. The most recent transaction as insider was on May 15, 2025, when has been sold 3,000 shares (Common Stock) at a price of $1.03 per share, resulting in proceeds of $3,090. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3K
n/a 3M change
n/a 12M change
Total Value Held $6,120

Mark S Forman Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 15 2025
BUY
Grant, award, or other acquisition
$3,090 $1.03 p/Share
3,000 Added 50.0%
3,000 Common Stock

Also insider at

PASG
Passage BIO, Inc. Healthcare
MSF

Mark S Forman

Chief Medical Officer
Philadelphia, PA

Track Institutional and Insider Activities on VTYX

Follow Ventyx Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VTYX shares.

Notify only if

Insider Trading

Get notified when an Ventyx Biosciences, Inc. insider buys or sells VTYX shares.

Notify only if

News

Receive news related to Ventyx Biosciences, Inc.

Track Activities on VTYX